BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29534718)

  • 1. Ras enhances TGF-β signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1.
    Liu S; Iaria J; Simpson RJ; Zhu HJ
    Cell Commun Signal; 2018 Mar; 16(1):10. PubMed ID: 29534718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
    Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
    J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPSB1-mediated inhibition of TGF-β receptor-II impairs myogenesis in inflammation.
    Li Y; Dörmann N; Brinschwitz B; Kny M; Martin E; Bartels K; Li N; Giri PV; Schwanz S; Boschmann M; Hille S; Fielitz B; Wollersheim T; Grunow J; Felix SB; Weber-Carstens S; Luft FC; Müller OJ; Fielitz J
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1721-1736. PubMed ID: 37209006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
    Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
    Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics profiling of Madin-Darby canine kidney plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-beta-mediated epithelial-mesenchymal transition.
    Chen YS; Mathias RA; Mathivanan S; Kapp EA; Moritz RL; Zhu HJ; Simpson RJ
    Mol Cell Proteomics; 2011 Feb; 10(2):M110.001131. PubMed ID: 20511395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HILI inhibits TGF-β signaling by interacting with Hsp90 and promoting TβR degradation.
    Zhang K; Lu Y; Yang P; Li C; Sun H; Tao D; Liu Y; Zhang S; Ma Y
    PLoS One; 2012; 7(7):e41973. PubMed ID: 22848678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus.
    Jiang B; Zhang JS; Du J; Urrutia R; Barnard J
    Cell Signal; 2003 Jul; 15(7):699-708. PubMed ID: 12742230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Damage Activates TGF-β Signaling via ATM-c-Cbl-Mediated Stabilization of the Type II Receptor TβRII.
    Li Y; Liu Y; Chiang YJ; Huang F; Li Y; Li X; Ning Y; Zhang W; Deng H; Chen YG
    Cell Rep; 2019 Jul; 28(3):735-745.e4. PubMed ID: 31315051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
    Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
    J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells.
    Gaedeke J; Noble NA; Border WA
    Kidney Int; 2004 Jul; 66(1):112-20. PubMed ID: 15200418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.
    Fernandez T; Amoroso S; Sharpe S; Jones GM; Bliskovski V; Kovalchuk A; Wakefield LM; Kim SJ; Potter M; Letterio JJ
    J Exp Med; 2002 May; 195(10):1247-55. PubMed ID: 12021305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
    Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
    Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPSB1-mediated HnRNP A1 ubiquitylation regulates alternative splicing and cell migration in EGF signaling.
    Wang F; Fu X; Chen P; Wu P; Fan X; Li N; Zhu H; Jia TT; Ji H; Wang Z; Wong CC; Hu R; Hui J
    Cell Res; 2017 Apr; 27(4):540-558. PubMed ID: 28084329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP70 decreases receptor-dependent phosphorylation of Smad2 and blocks TGF-β-induced epithelial-mesenchymal transition.
    Li Y; Kang X; Wang Q
    J Genet Genomics; 2011 Mar; 38(3):111-6. PubMed ID: 21477782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib suppresses TGF-β responses by inducing caveolae/lipid raft-mediated internalization/degradation of cell-surface type II TGF-β receptors: Implications in development of effective adjunctive therapy for hepatocellular carcinoma.
    Chung CL; Wang SW; Sun WC; Shu CW; Kao YC; Shiao MS; Chen CL
    Biochem Pharmacol; 2018 Aug; 154():39-53. PubMed ID: 29678520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.